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ABSTRACT 
In the presence of extracellular calcium and magnesium, a series of chemotactic 
oligopeptides and C5a caused aggregation of human polymorphonuclear neutro- 
phils (PMNs). This cellular response developed rapidly and began to reverse 2 
min after exposure to the chemotactin. In the absence of the bivalent cations, 
none of the chemotactins stimulated the aggregation response, If cells were first 
exposed  to  a  chemotactin  and  then  treated  with  calcium  and  magnesium, 
aggregation was detected only after addition of the cations, and the magnitude of 
the response fell sharply as the interval between the addition of chemotactin and 
addition of cations was lengthened: when this interval exceeded 2 rain, aggrega- 
tion was barely detectable. This loss of reactivity persisted even when cells were 
re-exposed to fresh chemotactic factor and washed between the first and second 
exposures. In all instances, however, loss of cellular reactivity was highly selective: 
cells  preincubated  with  any chemotactic oligopeptide were  hyporesponsive to 
subsequent  stimulation with an oligopeptide but  remained fully responsive  to 
C5a; cells preincubated with C5a were hyporesponsive to C5a but retained their 
responsitivity to the oligopeptides. Because this selectivity  parallels the known 
specificities of these chemotactic factors for their receptors in or on the neutrophil, 
desensitization may reflect functional loss of receptors after stimulation. Alterna- 
tively,  this  selectivity may indicate  that  morphologically identical  neutrophils 
contain subpopulations of cells with varying reactivities to receptor-bound chem- 
otactic  factors.  In  either  event,  desensitization may be  useful  in  functionally 
defining  chemotactic  factors  and  their  respective  receptors.  The  rapidity  of 
development of desensitization suggests that it may operate to limit or moderate 
various in vitro and in vivo neutrophil responses to chemotactic factors. 
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In  stimulating  polymorphonuclear  neutrophii 
(PMN) responses such as chemotaxis, exocytosis, 
and cellular aggregation, certain chemotactic fac- 
tors first interact with stereospecific, high-affinity 
receptors in or on the celt (5,  7,  16, 28, 33, 36, 
40).  Synthetic  oligopeptide  chemotactic  factors 
appear to bind to one receptor; the chemotactic 
fragment of human C5, C5a, appears to bind to a 
quite different receptor (1, 2, 8, 16, 28, 33, 36, 
39).  Receptor  binding seems essential for  the 
biological activities of these chemotactic factors, 
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cellular responses to the chemotactic factors (1,2, 
28,  33,  36,  39).  In  the presence  of extracellular 
Ca  2+, chemotactic factors stimulate PMNs to take 
up Ca  z+ and increase their exchangeable intracel- 
lular Ca  2§ pool (4, 11, 12, 22, 23, 35). It has been 
postulated  that  these  events trigger or  modulate 
the  chemotactic  (4,  11,  12,  22),  degranulation 
(14,  15,  23,  35),  and  aggregation  (26,  31)  re- 
sponses  of the  cell.  One  important  consequence 
of chemotactic factor-receptor binding, therefore, 
may be alterations in surface membrane  permea- 
bility to Ca  2+. 
In  this  report,  we  studied  the  effect  on  the 
neutrophil  aggregation  response  of  withholding 
bivalent cations from cells treated with a  chemo- 
tactic factor.  In  the  presence  of Ca  2+  and  Mg  2+, 
PMNs  rapidly  aggregated  in  response  to  C5a  or 
the  chemotactic  oligopeptides;  in  the  absence  of 
these  cations,  the  cells  did  not  aggregate  but 
rather  rapidly became desensitized to subsequent 
treatment  with  the  bivalent  cations  and  fresh 
chemotactic  factor.  Desensitization  appeared  se- 
lective for the chemotactic factor receptor stimu- 
lated:  various chemotactic  oligopeptides desensi- 
tized  the  cells  to  further  stimulation  with  an 
oligopeptide but not to C5a; C5a desensitized the 
cells to further stimulation with C5a but not to the 
chemotactic  oligopeptides.  Thus,  the  desensitiza- 
tion procedure functionally defined the two chem- 
otactic  factor  receptors  and  may  be  useful  in 
defining other chemotactic  factor  receptors.  The 
rapidity  of  development  of  desensitization  sug- 
gests  that  chemotactic  factor  influences  on  the 
surface  membrane  permeability  to  Ca  z+  may  be 
short-lived, and that  desensitization  may serve to 
limit  in  vitro  and  in  vivo  PMN  responses  to 
chemotactic factors. 
MATERIALS  AND  METHODS 
Chemotactic Factors, Buffers, and Reagents 
C5a  was  generated  from zymosan-activated  normal 
human  sera and partially purified by gel filtration over 
Sephadex G100  as previously described (29,  38).  The 
reagent contracted guinea pig ileum, degranulated cyto- 
chalasin-B-treated  PMNs,  and  stimulated  PMN  and 
monocyte chemotaxis.  Virtually all  of the chemotactic 
activity  of the reagent could be inactivated by 30-min 
incubation  with  anti-human  C5  but  not  by  incubation 
with anti-human C3 or anti-human gammaglobulin (25, 
29).  The  synthetic  oligopeptide  chemotactic  factors 
N~-formyl-methionyl-leucyl-phenylalanine  (FMLP), N ~- 
formyl-methionyl-methionyl-  phenylalanine  (FMMP), 
N~- formyl-methionyl-methionyl-  methionyi- methionine 
(FMMMM),  and  N~-formyl-norleucyl-leucyl-phenylala  - 
nine  (FNLLP)  were  obtained  and  used  as  previously 
described (8, 34). The four oligopeptides had chemotac- 
tic activities of 9.4, 3.1, 2.2, and l, respectively (8, 34). 
The  tritium-labeled  oligopeptide, N"-formyl-norleucyl  - 
leucyl  [p-tritio]-phenylalanine  ([3H]FNLLP),  was  syn- 
thesized to high specific activity  (14 Ci/mmol) as previ- 
ously described (8). Each of the oligopeptides at 10 mM 
was dissolved  in dimethylsulfoxide. In the final concen- 
trations  used  here  (0.3%  or less),  the solvent did not 
influence  PMN  function.  The  buffer  used  throughout 
these studies  was a modified Hanks' balanced salt solu- 
tion containing (mM): NaCI, 130; KC1, 5.5; Na2HPO4, 
0.6; NaH2PO4,  0.6;  glucose,  10; and Tris, 25.  Where 
indicated, Ca  .'+ and Mg  2§ were added as chloride salts in 
a final  concentration of 1.4  and 0.7  mM, respectively. 
Chemicals were reagent grade. 
Chemotactic Assays 
Assays  of  chemotactic  substances  were  performed 
using modified Boyden chambers, Millipore filters (Mil- 
lipore Corp., Bedford, Mass.) of 0.65-/zm porosity, and 
dextran-sedimented  human  leukocytes (27).  Chambers 
were incubated for 45 rain at 37~  and chemotaxis was 
scored by  averaging the  number of cells migrating  10 
/xm or farther into the filter in five high-power fields. 
The dose-response curves obtained over a 105-fold dilu- 
tion  of chemotactic  substance  were  plotted  and  from 
these  curves  the  concentration  of chemotactin  which 
stimulated  50%  of the  maximal chemotactic response 
(EDs0) was extrapolated (24).  Data are reported as the 
ED~o. 
Aggregation  Assay 
Normal  human  whole  blood  was  centrifuged  over 
FicolI-Hypaque discontinuous gradients to obtain leuko- 
cyte populations consisting  of 98.4%  PMNs (27).  The 
neutrophil preparation was freed of contaminating eryth- 
rocytes by hypotonic lysis, washed in isotonic saline, and 
suspended in the buffer at a cell concentration of 4,600/ 
ill  -+  1,000//xl  (range).  All reagents were made 37~ 
an~  pH 7.4 before use,  and  all experiments were per- 
formed in  a 37~  room.  1 ml of the PMN suspension 
was placed in a plastic vial and stirred continuously with 
a  magnetic  bar.  After  1-4  rain  (time  specified),  the 
suspension  was treated with 1.4 mM Ca  z§ and 0.7 mM 
Mg  z§ (final concentrations) and, after 1 min more, with 
a small volume (50/xl or less) of chemotactic substance. 
In some experiments, the order of adding the bivalent 
cations and chemotactic substance  was reversed, and the 
interval between the two additions was varied. In other 
experiments,  cell  suspensions  were  exposed  to  fresh 
chemotactic  factors  1  min  after  adding  the  bivalent 
cations to cells preincubated for 4 min with a chemotactic 
factor. Finally, in some experiments, cells were washed 
after  4  rain  of preincubation  with  a  chemotactin  but 
before addition of the bivalent cations. 
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rain after adding a  chemotactin or the bivalent cations 
(depending on the particular experimental design), 20- 
/zl  samples  were  taken  from  the  PMN  suspension, 
immediately diluted in  10 ml of Isoton (Coulter Elec- 
tronics Inc.,  Hialeah,  Fla.),  and  analyzed  in  a  model 
ZBI  Coulter  Counter  (Coulter  Electronics Inc.).  The 
counter  aspirates  500  /.d  from  the  Isoton-diluted cell 
suspension and electronically enumerates and sizes  (by 
volume) each particle (i.e., single cell or cell clump) in 
the  aspirate.  The  counter  can  be  set  to  selectively 
enumerate only  particles with  a  volume  size  within  a 
specified  range.  To  detect  aggregation  of  cells,  we 
performed  two  counts on  each Isoton-diluted suspen- 
sion. The first count, called T, was performed with the 
following  settings  for  amplification,  aperture,  upper 
threshold, and lower threshold: 1/4, 4, infinity, and 10, 
respectively; the second count, called A, was performed 
with the following values: 1/4, 4, infinity, and 80, respec- 
tively. With these settings, the T  count enumerates all 
particles larger than ~20%  of the  size  of the average 
PMN,  and the A  count enumerates all  particles larger 
than ~180% of the average PMN size (27). Thus, T is 
the  total  particle  concentration  (i.e.,  aggregated  plus 
unaggregated cells); A is the aggregated cellular concen- 
tration; and 100  x  A/T is the large particle percentage 
(LPP). We have found that various chemotactic factors 
stimulate  PMNs  in  suspension  to  (a)  aggregate  into 
doublets and triplets of cells, and (b) swell  individually 
(25-27,  31).  The  former effect creates  particles  with 
volume sizes twice and three times the size of the average 
PMN; the latter effect enlarges the particle sizes by no 
more than 20% (25, 27). Hence, the A and LPP values 
reflect aggregation but not cellular swelling  (27). 
To  facilitate comparisons  between  different  experi- 
ments, the maximum change in the large particle per- 
centage (MLPP) was calculated. The MLPP is: 
MLPP =  LPPm -  LPP,, 
where LPPm is the largest LPP found at either ~/4, V2, 1, 
2,  4,  8,  or  15  min after adding a  chemotactin to  the 
PMN suspension, and LPP,, is the LPP found just before 
the addition. 
Washing Procedure 
In some studies, 1.5 ml of a bivalent cation-free PMN 
suspension was incubated with a chemotactic factor for 4 
min and then  immediately transferred with a  glass  pi- 
pette to a plastic conical tube and centrifuged for 10 s in 
an Eppendorf Microcentrifuge (Brinkmann Instruments, 
Inc., Westbury, N. Y.) at 8,000 g. More than 95% of 
the supernatant fluid was removed, the cells were resus- 
pended in  1.5  ml of the buffer and recentrifuged, and 
the supernatant fluid was again removed. The cell button 
was resuspended in 1.0 ml of buffer. The suspension was 
transferred to plastic vials and treated as in the above 
experiments. This washing procedure took <  5 min and 
appeared not to alter PMN function. It was important to 
determine the efficacy of washing in freeing cells of a 
chemotactic  substance.  When  PMN  suspensions were 
incubated with 5  ￿  10 4  M  FNLLP,  1% of which was 
tritium-labeled, the washing procedure freed the cells of 
99.93% of the original label. 
Thin-Layer Chromatography 
In  some  experiments,  the  PMN  suspensions  were 
preincubated with 1 x  I0 -r M tritium-labeled [aH]FNLLP 
for 4 and 30 min under conditions similar to those in the 
aggregation assay. The cell suspension was centrifuged 
with the Brinkmann Microcentrifuge, and the superna- 
tant  fluid  was  run  on  glass-backed  silica  gel  (Sigma 
Chemical Co., St. Louis, Mo.) plates to study degrada- 
tion of the tripeptide. The supernatant fluid was applied 
to the plates and allowed to run for 3 h in an n-butanol/ 
water/acetic acid (6:l:1) solvent system as described in 
reference  8.  Nonformylated peptides  and  amino acids 
were  located  by ninhydrin staining of the  plates.  The 
stained areas of the plates were scraped off, placed in 5 
ml of Aquasol (New England Nuclear, Boston, Mass.), 
and  measured  for  fluorescence  in  a  Searle  Mark  III 
Scintillation Counter (Searle Analytic, Inc., Des Plaines, 
II1.) recording at an efficiency of >60%. 
RESULTS 
Neutrophil Aggregation 
Neutrophils  preincubated  for  2  rain  in  Ca  ~+- 
and  Mg2+-containing buffer  aggregated  after ex- 
posure  to  5  x  10 -6  M  FMLP  or  50  /xl/ml C5a. 
This effect was shown by the rapid rise in the LPP 
of  PMN  suspensions  found  after  adding  either 
agent  (Fig.  1,  solid  lines).  Changes  in  the  LPP 
peaked  within 2  min of the  addition  and  abated 
thereafter.  Dose-response  curves for FMLP  indi- 
cated  that this response  was  not  detected  below 
1.7  x  10  s M, increased progressively with incre- 
mental increases in FMLP concentrations between 
1.7  x  10 -s and 5  x  10 -7 M, and plateaued above 
5  x  10 -7  M;  similar curves for C5a  showed  that 
the response was not detected below 5  /xl/ml and 
increased progressively with increases in C5a con- 
centrations between  5  and  50  p.1/ml,  the  highest 
concentration  used  (not  shown).  In  appropriate 
concentrations,  FMMP,  FMMMM,  and  FNLLP 
induced  similar  changes  in  the  LPP.  These  re- 
sponses were  not  found  when  cells were  treated 
with  various  nonchemotactic  proteins,  oligopep- 
tides, and other reagents (24-28, 30, 31). 
Cation Requirements and Loss of Cell 
Reactivity 
In the absence of Ca e+ and Mg  2+, 5  x  10 ~  M 
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/zl/ml C5a (Fig. 1, lowest line of lower panel) did 
not aggregate the cells. A similar lack of reactivity 
was found when cells were  treated with various 
amounts of  C5a,  FMLP,  or  other  chemotactic 
oligopeptides in the  absence of bivalent cations 
(not shown). Apparently, bivalent cations as well 
as proper concentrations of a chemotactic factor 
are required for the aggregation response. When 
the normal sequence of adding the bivalent  cations 
and chemotactic factor was reversed, aggregation 
was  detected  only after  addition of the  cations. 
The interrupted lines of Fig. 1 show that changes 
in the  LPP  were  successively blunted when the 
bivalent cations were added simultaneously with, 
or  at  V:,  1,  or  2  min after,  addition of FMLP 
(upper panel) or C5a (lower panel). Adding the 
bivalent cations at 4 or 8 min after either chemo- 
tactic  factor  also  resulted  in  no  response  or  a 
minimal response (not shown). Therefore, delay 
in  adding bivalent cations for  2  min or  longer 
results in an almost total loss of cellular reactivity. 
Desensitization  and its Selectivity 
This loss in PMN reactivity was also found when 
cells were re-exposed to fresh chemotactic factor. 
Cells were incubated in bivalent cation-free buffer 
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FIGURE  1  Effect  of the time and sequence of addition 
of chemotactic factor and bivalent cations on the large 
particle  percentage  of  PMN  suspensions. Cells were 
exposed to 5 x 10 -~ M FMLP (upper panel) or 50/xl/ml 
C5a (lower panel) and, at the indicated times before and 
afterwards, treated  with Ca  2+  and Mg  2+.  The  bottom 
curve of each panel indicates experiments in which cells 
were not exposed to the bivalent cations. The numbers 
in parentheses are the number of separate experiments 
performed. 
for 4 min with 50/zl/ml C5a (Fig. 2, upper panel) 
or 5  x  10 4  M  FMLP (Fig. 2, lower panel) and 
then treated with Ca  2+ and Mg  2+.  1 min thereaf- 
ter, cells were again exposed to 50  /xl/ml C5a, 5 
x  10 4  M FMLP, or no chemotactic factor. Cells 
preincubated with C5 a aggregated minimally  upon 
re-exposure to C5a (Fig. 2, lowest curves of upper 
panel) and cells preincubated with  FMLP  were 
similarly unreactive to re-exposure to FMLP (Fig. 
2, lowest curves of lower panel). In striking con- 
trast to these results were the results found when 
PMNs were preincubated with C5a or FMLP and 
then exposed to the opposite chemotactic factor. 
Cells preincubated with  C5a  were  normally re- 
sponsive to  FMLP,  and cells preincubated with 
FMLP showed a prominent, sustained response to 
C5a  (Fig.  2,  two  upper curves  of each  panel). 
Thus, loss in PMN reactivity was highly selective. 
This selective loss of PMN reactivity also occurred 
when cells first incubated with comparatively low 
concentrations of FMLP or C5a before exposure 
to  5  ￿  10  --6  M  FMLP  or  50  /zl/ml C5a.  Cells 
preincubated with  1.7  x  10 -r  to  5  x  10 4  M 
FMLP were hyporesponsive to further stimulation 
with the FMLP but normally responsive to further 
stimulation with the  C5a  (Fig.  3.  upper panel), 
and PMNs preincubated with 5  to 50  /zl/ml C5a 
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PIGURE  2  Specificity  of  neutrophil  desensitization. 
Cells were preincubated with C5a, FMLP, or buffer for 
4  rain and  then  treated  with Ca  2+  and  Mg  2§  1 min 
thereafter, cells were exposed to fresh C5a, FMLP, or 
buffer. In these experiments, the concentrations of C5a 
and FMLP were 50/zl/ml and 5 x 10 ~ M. The numbers 
in parentheses are the number of separate experiments 
performed. 
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Presence and Specificity of Neutrophil Desensitization Induced by C5a and Various 
Oligopeptide Chemotactic Factors* 
Desensitizing agent (used in pretreating cells) 
Aggregating agent  None  C5a (50/zl/ml)  FMLP (1.7 ￿  10 -~ M) 
C5a (50 ,o.l/ml)  5.1  -+ 1.0 (10)r  1.1  -+ 0.2 (11)w  4.9 -+ 1.2 (20)~stl 
FMLP (I .7 x  10 7 M)  4.8 -+ 1.0 (9)  6.1 -+ 0.7 (5y  r  1.8 -+ 0.3 (6)w 
FMLP (5 x  10  -~ M)  10.6 -+ 1.0 (14)  9.6 -+ 1.1  (11)  ss  4.I  -  1.3 (6)w 
FMMMM (5 x  10  4  M)  10.1 -+ 2.2 (6)  7.5 _+ 2.0 (5)  ss  ND 
* The cells were incubated with the indicated concentration of desensiti~ng agent for 4  min and then exposed  to 
1.4 mM Ca  =+ and 0.7 mM Mg  =+.  1 min thereafter the cells were treated with the indicated concentration  of 
aggregating agent and the maximal change in the large particle percentage was recorded. 
$ Maximal change in the large particle percentage,  -+ SEM. The number of separate experiments performed is in 
parentheses. 
w P  <  0.05 compared  to cells preincubated with no desensitizing agent but exposed to the same concentration of 
aggregating agent. 
dl NS, no significant difference compared to cells preincubated with no desensitizing agent but exposed to the same 
concentration of aggregating agent. 
ND, not done. 
12- 
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FIGURE 3  Effect of the concentration of chemotactic 
factor in the preincubate on the desensitization of neu- 
trophils. Cells were preincubated for 4  rain with the 
indicated concentration of FMLP (upper panel) or C5a 
(lower panel), treated with Ca  ~+ and Mg  ~§  for 1 min, 
and then exposed to 5 x  10 -~ M FMLP (solid lines) or 
50/zl/ml C5a (interrupted lines). Each point is the mean 
of the maximal change in the large particle percentage 
found for at least six experiments. 
were  hyporesponsive to  further stimulation with 
the C5a but normally responsive to further stimu- 
lation with the FMLP (Fig. 3, lower panel). 
Apparently, PMNs incubated with a chemotac- 
tic factor in the absence of bivalent cations rapidly 
become desensitized to that chemotactic factor. In 
experiments  performed  in  a  manner similar  to 
those  of  Fig.  2,  cells  were  preincubated  with 
diverse  oligopeptide  chemotactic  factors  for  4 
rain,  treated  with  bivalent cations,  and  1  min 
thereafter  were  re-exposed  to  fresh  chemotactic 
factor. Table I shows that cells preincubated with 
FMLP,  FMMMM,  FMMP,  or FNLLP were  re- 
fractory to subsequent stimulation with FMLP or 
FMMMM but retained their responsitivity to C5a; 
cells preincubated with C5a became refractory to 
subsequent  stimulation  with  C5a  but  retained 
their  responsitivity  to  FMLP  and  FMMMM. 
These data indicate that the  specificity  of loss  in 
PMN  reactivity parallels the  specificity  of PMN 
receptors for the chemotactic factors. 
Retention of Biological Activity of 
Chemotactic Factors during Incubation with 
Cells 
It is possible that during the 4-min incubation 
period  PMNs  inactivate the  chemotactic  factors 
and/or generate inhibitors to them. However, we 
found that the supernatant fluid of PMN suspen- 
sions exposed to FMLP or C5a for 4 min retained 
its  chemotactic  and  aggregating  activities when 
assayed against fresh cells  (Table II). Moreover, 
the supernatant fluid was able to desensitize selec- 
tively  fresh  PMNs  (Fig.  4).  Finally,  thin-layer 
chromatography  of  the  supernatant  fluid  of 
[ZH]FNLLP-treated PMN  suspensions could de- 
tect  no  or  minimal degradation  of  the  labeled 
oligopeptide during the  4  rain  it  was  incubated 
with the cells, although definite degradation was 
detected  after  30  min of  incubation (see  Table 
III), as has been reported previously (2). It seems, 
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Desensitizing agent (used in pretreating cells) 
FMLP (5  ￿  10 ~  M)  FMMMM (5  ￿  10 ~  M)  FMMMP (5  ￿  1() ~  M)  FNLLP (3  ￿  10  s M) 
7.1  •  1.5 (20)  ~s  6.0 -+  1.0 (3)  "s  6.0 ~  2.1  (4)  ~s  9.7  -'-" 4.6 (4)  ss 
ND￿82  0.6 +- 0,7 (3)w  0.2  --- 0.2 (3)w  0.8 -+ 0.3 (3)w 
1.7 -+ 0.4 (8)w  ND  ND  ND 
1.0 -~ 0.5 (3)w  3.2  -+  1.5 (5)w  1.5  -+ 0.5 (3)w  2.1  ~  1.3 (3)w 
TABLE  II 
Comparison of the Chemotactic and Aggregating Activities of FMLP, C5a, and the Supernatant Fluid of FMLP- 
or CSa-  Treated Neutrophils 
Activity measured 
Chemotactic substance  Chemotaxis* ED~  Aggregation~ MLPP 
FMLP  5.9 x  10 -9 +_ 2.1  ￿  10 -9 M (3)w  4.8 -  1.0 (9) 
Supemate of FMLP-treated cells  4.4 ￿  10 -9 +  1.2  ￿  10 ~  M (4)  5.9 -+ 1.4 (6) 
C5a  3.1  -+ 2.0 tzl/ml (3)  NDII 
Supernate of C5a-treated cells  2.7 -+  1.4/zl/ml (3)  ND 
* Chemotaxis of dextran sedimented human leukocytes was performed as described in Materials and Methods. 1 ml 
of 5  x  10 -6 M FMLP, 50 p.1/ml C5a, or of supematant fluid taken from cell suspensions incubated with 5  ￿  10  4 
M FMLP or 50/.~l/ml C5a for 4 min was serially diluted over a 105-fold range and assayed for chemotactic activity. 
The EDs0 was extrapolated from dose-response curves. 
~: Neutrophils were preincubated with 1 ml of buffer for 4 min, treated with Ca  z§ and Mg  z+, and 1 min thereafter 
exposed to  1.7  ￿  10 -r M  FMLP or 35  p,l of supematant fluid taken from cells preincubated with 5  ￿  10 -6 M 
FMLP for 4 min. Since the 35 /zl of supematant fluid was added to 1 ml of PMN suspension, the ~alculated final 
concentration of FMLP in these experiments was 1.7 ￿  10 -7 M. 
w Mean -+ SEM for the number of separate experiments given in parentheses. 
U  ND, not done. 
therefore, that during the 4-min incubation period 
the fluid phase of the PMN  suspensions contains 
full  chemotactic,  aggregating,  and  desensitizing 
activity  and  that  prominent  degradation  of  the 
chemotactin or  generation  of inhibitors does not 
occur  under  the  experimental  conditions  used 
here. 
Desensitization after Cell Washing 
The data suggest that loss in PMN reactivity to 
chemotactic factors is a cellular phenomenon. This 
suggestion  is  supported  by experiments  in which 
cells were washed after exposure to a chemotactin. 
Cells were  preincubated with 5  ￿  10-* M  FMLP 
or 50  /xl/ml CSa in buffer free of bivalent cations 
for 4  rain and then rapidly washed.  (The washing 
procedure  removed  >99.9%  of labeled FNLLP; 
see  Materials  and  Methods.)  Cells  were  resus- 
pended  in  fresh  buffer  for  1  min,  treated  with 
bivalent cations,  and  1  rain  thereafter  were  ex- 
posed to fresh FMLP  (5  x  10-* M), C5a  (50/xl/ 
ml),  or neither chemotactin.  The PMNs preincu- 
bated with either chemotactic factor before wash- 
ing showed no tendency to aggregate when resus- 
pended  in  fresh buffer and treated  with bivalent 
cations  (not  shown).  Cells  preincubated  with 
FMLP  before  washing  were  hyporesponsive  to 
FMLP but not to C5a  (Fig.  5,  upper panel), and 
cells preincubated with C5a  before washing were 
hyporesponsive to C5a but not to FMLP  (Fig. 5, 
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CHEMOTACTIC FACTOR 
FIGURE  4  Desensitizing activity  of supematant fluids 
obtained from  PMN  suspensions treated with D~,ILP or 
C5a.  Fresh PMNs  were placed in the supematant fluid 
obtained  from  cell  suspensions  preincubated  for 4  min 
with 5 x  10 ~  M FMLP, 50 #l/ml C5a, or no chemotac- 
tic factor. After 1 rain the cells were treated with Ca  z+ 
and  Mg  2+  and  1  min  later  with  5  ￿  10 ~  M  FMLP 
(upper  panel)  or  50  /xl/ml  C5a  (lower  panel).  The 
number in parentheses is the number of separate exper- 
iments performed. 
TABLE III 
Degradation of Tritium-labeled  FNLLP Into 
Phenylalanine  and Unidentified  Products by 
Neutrophils * 
Percent of total  label  co-migrating  with 
rain of Incu- 
bation  FNLLP  Phe  Unidentified$ 
0  >80 (3)w  4.9 -+ 0.5 (3)11  6.O _+ 0.6 (3) 
4  >80 (2)  5.0 (2)  7.5 (2) 
30  62  11.6 (1)  13.6 (1) 
* 4,600  Cells//xl  were  incubated  with  1.0  ￿  10 -r  M 
FNLLP (tritiated in the para position  of phenylalanine 
[phe])  for the  indicated  time.  After incubation,  the 
supernatant  fluid  of the  neutrophil  suspensions  was 
assayed  for degradation of FNLLP by measuring the 
percentage  of label  which  co-migrated with  FNLLP 
and phenylalanine. 
1: Percentage of label migrating to spots not identified as 
FNLLP or phenylalanine. 
w Number of separate experiments in parentheses. 
II +- SEM. 
lower panel).  Fig. 5  does show that washed cells 
appeared  to regain some of their responsitivity to 
the  desensitizing  chemotactic  agent  compared  to 
unwashed cells (see Fig. 2). Nevertheless, the data 
suggest  that  a  major portion  of the  loss in PMN 
reactivity results from cellular mechanisms. 
DISCUSSION 
Eosinophils (13), basophils (3,  19, 32), mast cells 
(9,  10),  and neutrophils (17, 37) lose their ability 
to  directionally  migrate  and/or  degranulate  in 
response  to  immunologic  stimuli  when  they  are 
preincubated  with  these  stimuli under  conditions 
which  do  not  support  these  responses.  In  these 
instances,  loss  of  reactivity  is  specific  for  the 
stimuli with which the ceils were preincubated and 
persists  after  cell  washing:  the  cells  themselves 
have become desensitized or deactivated towards 
certain  stimuli.  We  preincubated  PMNs  with 
chemotactic factors under conditions not support- 
ing cellular aggregation (i.e.,  lack of extracellular 
Ca  2+  and  Mg  2+)  and  studied  the  effect  of  this 
treatment  on  the  normally occurring  aggregation 
response  to  chemotactic  factors when  conditions 
supporting  aggregation  were  restored  (i.e.,  addi- 
tion  of  Ca 2+  and  Mg"+).  We  found  that  PMNs 
preincubated  with chemotactic factors rapidly lost 
their  ability to  aggregate  in  response  to  bivalent 
cations  (Fig.  1).  This  loss  persisted  when  cells 
were retreated with fresh chemotactic factor after 
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FIGURE 5  Persistence  of  neutrophil  desensitization 
after washing.  Cells were preincubated with FMLP (5  ￿ 
10 -~ M, C5a (50 /~l/ml), or no chemotactic factor for 4 
min  in  bivalent  cation-free  buffer  and  then  rapidly 
washed  and  resuspended  in  fresh buffer.  After  1 min 
cells were treated with Ca  2+ and Mg  z+ and  1 min later 
exposed to 5 x  10 -6 M FMLP (upper panel) or 50 p.l/ml 
C5a  (lower panel).  The  number  in  parentheses  is the 
number of separate experiments performed. Cells prein- 
cubated  with  either  or  no  chemotactic factor  did  not 
aggregate  when  exposed  to  buffer  after  washing  and 
treating with bivalent cations (not shown). 
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concentrations of the  chemotactin  before adding 
the bivalent cations and fresh chemotactic factor 
(Fig. 3). Desensitization to the chemotactic factors 
was strikingly specific: cells preincubated with one 
of  the  chemotactic  oligopeptides  were  hypore- 
sponsive to the oligopeptides but not to CSa; cells 
preincubated  with  C5a  were  hyporesponsive  to 
C5a but not to the oligopeptides (Table I). During 
the 4-min preincubation period, the fluid phase of 
the  PMN  suspensions  retained  its  chemotactic 
(Table II), aggregating (Table II), and desensitiz- 
ing activities  (Fig.  4)  and  we could find  no evi- 
dence  for  the  generation  of chemotactic  factor 
inhibitors  nor  for the  degradation  of tritium-la- 
beled  FNLLP  (Table  III).  Rather,  the  PMNs 
themselves were hyporesponsive to the chemotac- 
tic factors and this effect persisted  after the cells 
were washed (Fig. 5). PMNs handled in this way 
did  not release  lysosomal enzyme contents  (27, 
31).  We conclude that  the aggregation response 
of PMNs can be desensitized to specific chemotac- 
tic factors in a manner similar to the desensitiza- 
tion  of  the  chemotactic  and  degranulation  re- 
sponses of eosinophils,  basophils,  mast cells  and 
PMNs.  The  desensitization  studied  here  appears 
to reflect the specificity of the chemotactic factors 
for their respective receptors in or on the neutro- 
phil. A  stimulus-induced, functional loss of chem- 
otactic factor receptors may underlie the desensi- 
tization phenomenon. 
If neutrophils are functionally homogeneous in 
their  reactivity  to  different  chemotactic  factors, 
then,  apparently,  stimulation  by receptor-bound 
chemotactins renders  the  cell  hyporesponsive  to 
further stimulation by agents interacting with the 
same receptor but not by agents interacting with a 
different receptor: the ability of the PMN to detect 
one type of stimulation has been abrogated by a 
functional  loss  of  one  type  of  receptor.  After 
binding a  chemotactic factor,  a  receptor may be 
degradated,  shed,  or  internalized,  or  it  may be 
continuously  occupied  without  further  stimula- 
tion.  However,  radiolabeled  chemotactic factors 
remain  associated  with  the  PMN  surface  mem- 
brane (1) and in continouous equilibrium with the 
extracellular  milieu  (1,  39).  Certain  effects  of 
receptor  binding,  therefore,  may  be  short-lived 
(as is suggested by the transiency of the aggrega- 
tion response) and insusceptible to repetitive stim- 
ulation  by  the  same  receptor.  Changes  in  the 
surface  membrane  permeability  to Ca  2.  may be 
such an effect.  Chemotactic factors stimulate  an 
influx  and  intracellular  accumulation of Ca  2+ (4, 
11, 12, 22, 23, 35). These events may trigger the 
aggregation  response  (26,  31)  and,  obviously, 
would  not  occur in  the  absence  of extracellular 
Ca  2+. Rapid but short-lived effects on the mem- 
brane permeability to Ca  2+ may explain the rapid 
and  short-lived  aggregation  response  and  the 
equally  rapidly  developing  desensitization  phe- 
nomenon.  Selective  desensitization  may indicate 
an  inability  of the  receptor  to  repeatedly  alter 
membrane permeability under conditions in which 
a previously unstimulated receptor could. 
In the aggregation assay, as in some chemotactic 
and degranulation assays, only a small proportion 
of the cells can be definitely identified as respond- 
ing to a chemotactic factor (18, 33, 40). Morpho- 
logically homogeneous PMNs may consist of sub- 
populations  of  cells  with  varying  reactivity  to 
different chemotactins. Thus, the aggregation re- 
sponse  to  a  particular  type  of chemotactin  may 
involve a particular subset of cells; desensitization 
may indicate that cells once stimulated are refrac- 
tory to all chemotactic factors, and the specificity 
of desensitization may result from the response of 
cells  not  sensitive  to  the  particular  chemotactic 
factor in  the preincubate.  Changes in membrane 
permeability  to Ca  2+,  therefore,  may occur only 
once  in  a  cell  and  the  cell  may  then  become 
insusceptible  to further changes regardless of the 
type of subsequent chemotactic stimuli. 
Whether the specificity of desensitization results 
from receptor specificity of functionally homoge- 
neous cells  or  from  subpopulation  specificity of 
functionally heterogeneous cells, our data indicate 
that  specific  desensitization  does  occur  and  is 
importantly related to the role of bivalent cations 
in cellular responsitivity.  Desensitization  may be 
useful in defining receptor specificities  of chemo- 
tactic  factors.  Desensitization  may also  serve  to 
limit in vitro and in vivo responses to chemotactic 
factors.  The  rapid  reversal  of  the  aggregation 
response  and  its  close  timing  with  the  develop- 
ment of desensitization  suggest that ceils  are be- 
coming desensitized  to the  chemotactic stimulus 
as they disaggregate. Animals infused with chem- 
otactic factors (29) or complement activators such 
as cobra venom factor (20, 29), zymosan (20), or 
antigen-antibody complexes (21) rapidly develop 
transient neutropenia. Similar neutropenia occurs 
in patients undergoing extracorporal hemodialysis 
(6).  In  each  of  these  conditions,  chemotactic 
factors may circulate freely and be responsible for 
the  neutropenia.  The  transient  nature  of  this 
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zation is occurring. 
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